South Korea In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMEMC0518DB-ST

Select Item

GlobalData’s “South korea In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the South korea In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.

The South korea In Vitro Diagnostics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for In Vitro Diagnostics Market.
• Global corporate-level profiles of key companies operating within the South korea In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

South Korea In Vitro Diagnostics Tests is segmented as follows:

• Cardiac Disease

• Clinical Chemistry

• Hematological Disorders

• Hormonal Disorder

• Infectious Disease

• IVD Analyzers and Reagents

• Metabolic Disorder

• Oncology

• Women's Health

Reasons to Buy

Key Reasons to Purchase – The South korea In Vitro Diagnostics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “South Korea In Vitro Diagnostics Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Siemens Healthineers AG

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 13

2.1 What Is This Report About? 13

2.2 In Vitro Diagnostics Market Segmentation 13

2.3 Definitions of Markets Covered in the Report 17

3 In Vitro Diagnostics Market, South Korea 43

3.1 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2015-2025 43

3.2 In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2018 45

3.3 In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2018 46

3.4 In Vitro Diagnostics Market, South Korea, Revenue ($m), 2015-2025 48

3.5 In Vitro Diagnostics Market, South Korea, Volume (Units), 2015-2025 51

3.6 In Vitro Diagnostics Market, South Korea, Volume (Units), 2015-2025 53

3.7 In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), 2018 56

4 Cardiac Disease Market, South Korea 58

4.1 Cardiac Disease Market, South Korea, Revenue Mix ($m), 2018 58

4.1.1 Cardiac Marker Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 60

4.2 Cardiac Disease Market, South Korea, Volume (Units), 2015-2025 63

4.2.1 Cardiac Marker Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 65

4.3 Cardiac Disease Market, South Korea, Average Price ($), 2015-2025 68

4.4 Cardiac Disease Market, South Korea, Distribution Share by Revenue ($m), 2018 70

4.5 Cardiac Disease Market, South Korea, Company Share by Revenue ($m), 2018 71

5 Clinical Chemistry Market, South Korea 73

5.1 Clinical Chemistry Market, South Korea, Revenue ($m), 2015-2025 73

5.1.1 Substrates Market, South Korea, Revenue ($m), by Segment, 2015-2025 75

5.2 Clinical Chemistry Market, South Korea, Volume (Units), 2015-2025 78

5.2.1 Substrates Market, South Korea, Volume (Units), by Segment, 2015-2025 80

5.3 Clinical Chemistry Market, South Korea, Average Price ($), 2015-2025 83

5.4 Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2018 85

5.5 Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), 2018 86

6 Hematological Disorders Market, South Korea 87

6.1 Hematological Disorders Market, South Korea, Revenue Mix ($m), 2018 87

6.2 Hematological Disorders Market, South Korea, Segment Contribution (%), 2018 88

6.3 Hematological Disorders Market, South Korea, Revenue ($m), 2015-2025 89

6.3.1 Hematology Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 91

6.3.2 Hemostasis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 94

6.4 Hematological Disorders Market, South Korea, Volume (Units), 2015-2025 97

6.4.1 Hematology Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 99

6.4.2 Hemostasis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 102

6.5 Hematological Disorders Market, South Korea, Average Price ($), 2015-2025 105

6.6 Hematological Disorders Market, South Korea, Distribution Share by Revenue ($m), 2018 109

6.7 Hematological Disorders Market, South Korea, Company Share by Revenue ($m), 2018 110

7 Hormonal Disorders Market, South Korea 112

7.1 Hormonal Disorders Market, South Korea, Revenue Mix ($m), 2018 112

7.1.1 Thyroid Function Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 114

7.2 Hormonal Disorders Market, South Korea, Volume (Units), 2015-2025 117

7.2.1 Thyroid Function Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 119

7.3 Hormonal Disorders Market, South Korea, Average Price ($), 2015-2025 122

7.4 Hormonal Disorders Market, South Korea, Distribution Share by Revenue ($m), 2018 124

7.5 Hormonal Disorders Market, South Korea, Company Share by Revenue ($m), 2018 125

8 Infectious Disease Market, South Korea 127

8.1 Infectious Disease Market, South Korea, Revenue Mix ($m), 2018 127

8.2 Infectious Disease Market, South Korea, Segment Contribution (%), 2018 128

8.3 Infectious Disease Market, South Korea, Revenue ($m), 2015-2025 130

8.3.1 Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 133

8.3.2 Clostridium difficile Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 135

8.3.3 Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 138

8.3.4 Hepatitis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 140

8.3.5 Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 142

8.3.6 Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 145

8.3.7 Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 147

8.3.8 Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 149

8.3.9 Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 151

8.3.10 Treponema pallidum Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 153

8.4 Infectious Disease Market, South Korea, Volume (Units), 2015-2025 156

8.4.1 Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 161

8.4.2 Clostridium difficile Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 163

8.4.3 Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 166

8.4.4 Hepatitis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 168

8.4.5 Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 170

8.4.6 Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 173

8.4.7 Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 175

8.4.8 Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 177

8.4.9 Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 179

8.4.10 Treponema pallidum Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 181

8.5 Infectious Disease Market, South Korea, Average Price ($), 2015-2025 184

8.6 Infectious Disease Market, South Korea, Distribution Share by Revenue ($m), 2018 190

8.7 Infectious Disease Market, South Korea, Company Share by Revenue ($m), 2018 191

9 IVD Analyzers and Reagents Market, South Korea 193

9.1 IVD Analyzers and Reagents Market, South Korea, Revenue Mix ($m), 2018 193

9.2 IVD Analyzers and Reagents Market, South Korea, Segment Contribution (%), 2018 194

9.3 IVD Analyzers and Reagents Market, South Korea, Revenue ($m), 2015-2025 195

9.3.1 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2015-2025 198

9.3.2 Hematology Analyzers Market, South Korea, Revenue ($m), by Segment, 2015-2025 200

9.3.3 Immunochemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2015-2025 203

9.3.4 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), by Segment, 2015-2025 206

9.4 IVD Analyzers and Reagents Market, South Korea, Volume (Units), 2015-2025 209

9.4.1 Clinical Chemistry Analyzers Market, South Korea, Volume (Units), by Segment, 2015-2025 212

9.4.2 Hematology Analyzers Market, South Korea, Volume (Units), by Segment, 2015-2025 214

9.4.3 Immunochemistry Analyzers Market, South Korea, Volume (Units), by Segment, 2015-2025 217

9.4.4 Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), by Segment, 2015-2025 220

9.5 IVD Analyzers and Reagents Market, South Korea, Average Price ($), 2015-2025 223

9.6 IVD Analyzers and Reagents Market, South Korea, Distribution Share by Revenue ($m), 2018 227

9.7 IVD Analyzers and Reagents Market, South Korea, Company Share by Revenue ($m), 2018 228

10 Metabolic Disorder Market, South Korea 230

10.1 Metabolic Disorder Market, South Korea, Revenue Mix ($m), 2018 230

10.1.1 Diabetes Assays Market, South Korea, Revenue ($m), by Segment, 2015-2025 232

10.2 Metabolic Disorder Market, South Korea, Volume (Units), 2015-2025 235

10.2.1 Diabetes Assays Market, South Korea, Volume (Units), by Segment, 2015-2025 237

10.3 Metabolic Disorder Market, South Korea, Average Price ($), 2015-2025 240

10.4 Metabolic Disorder Market, South Korea, Distribution Share by Revenue ($m), 2018 242

10.5 Metabolic Disorder Market, South Korea, Company Share by Revenue ($m), 2018 243

11 Oncology Market, South Korea 245

11.1 Oncology Market, South Korea, Revenue Mix ($m), 2018 245

11.2 Oncology Market, South Korea, Segment Contribution (%), 2018 246

11.3 Oncology Market, South Korea, Revenue ($m), 2015-2025 248

11.3.1 ALK Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 251

11.3.2 BRCA Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 253

11.3.3 Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 255

11.3.4 EGFR Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 257

11.3.5 HER2 Amplification Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 260

11.3.6 KRAS Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 262

11.4 Oncology Market, South Korea, Volume (Units), 2015-2025 264

11.4.1 ALK Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 267

11.4.2 BRCA Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 269

11.4.3 Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 271

11.4.4 EGFR Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 273

11.4.5 HER2 Amplification Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 276

11.4.6 KRAS Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 278

11.5 Oncology Market, South Korea, Average Price ($), 2015-2025 280

11.6 Oncology Market, South Korea, Distribution Share by Revenue ($m), 2018 284

11.7 Oncology Market, South Korea, Company Share by Revenue ($m), 2018 285

12 Women's Health Market, South Korea 287

12.1 Women's Health Market, South Korea, Revenue Mix ($m), 2018 287

12.2 Women's Health Market, South Korea, Segment Contribution (%), 2018 288

12.3 Women's Health Market, South Korea, Revenue ($m), 2015-2025 289

12.3.1 Prenatal Screening Market, South Korea, Revenue ($m), by Segment, 2015-2025 291

12.3.2 Reproductive Hormones and Proteins Tests Market, South Korea, Revenue ($m), by Segment, 2015-2025 294

12.4 Women's Health Market, South Korea, Volume (Units), 2015-2025 297

12.4.1 Prenatal Screening Market, South Korea, Volume (Units), by Segment, 2015-2025 299

12.4.2 Reproductive Hormones and Proteins Tests Market, South Korea, Volume (Units), by Segment, 2015-2025 302

12.5 Women's Health Market, South Korea, Average Price ($), 2015-2025 305

12.6 Women's Health Market, South Korea, Distribution Share by Revenue ($m), 2018 309

12.7 Women's Health Market, South Korea, Company Share by Revenue ($m), 2018 310

13 Overview of Key Companies in South Korea, In Vitro Diagnostics Market 312

13.1 F. Hoffmann-La Roche Ltd 312

13.1.1 Company Overview 312

13.2 Abbott Laboratories 312

13.2.1 Company Overview 312

13.3 Siemens Healthineers AG 312

13.3.1 Company Overview 312

13.4 Danaher Corp 313

13.4.1 Company Overview 313

13.5 Sysmex Corp 313

13.5.1 Company Overview 313

13.6 Beckman Coulter Inc 313

13.6.1 Company Overview 313

13.7 Qiagen NV 313

13.7.1 Company Overview 313

13.8 Horiba Ltd 314

13.8.1 Company Overview 314

13.9 Miraca Holdings Inc 314

13.9.1 Company Overview 314

13.10 Bio-Rad Laboratories Inc 314

13.10.1 Company Overview 314

13.11 Thermo Fisher Scientific Inc 315

13.11.1 Company Overview 315

14 In Vitro Diagnostics Market Pipeline Products 316

15 Financial Deals Landscape 320

15.1 Debt Offerings 320

15.1.1 Sugentech to Raise USD8.4 Million in Private Placement of Bonds Due 2024 320

15.2 Equity Offerings 321

15.2.1 TCM Bioscience to Raise Funds through IPO 321

15.2.2 Sugentech to Raise up to USD18.5 Million in Public Offering of Shares 322

15.3 Partnerships 323

15.3.1 Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 323

15.3.2 Volpara Solutions Enters into Distribution Agreement with ScreenPoint Medical 324

15.3.3 FutureChem Enters into Research Agreement with University of Colombia 325

15.3.4 Wellmarker Bio Enters into R&D Agreement with Cytogen 326

15.4 Venture Financing 327

15.4.1 3billion Raises USD9.5 Million in Series B Financing 327

15.4.2 Genopsy Raises USD8.5 Million in Series A Financing 329

15.4.3 Milu Labs Raises Funds through Seed Financing 330

16 Recent Developments 331

16.1 Corporate Communications 331

16.1.1 May 28, 2019: Macrogen receives GCLP accreditation 331

16.2 Financial Announcements 331

16.2.1 Nov 27, 2019: VUNO presents the future of medical AI solutions at RSNA 2019 331

16.2.2 Oct 30, 2019: GC Pharma reports Q3 2019 results 333

16.2.3 Jul 30, 2019: GC Pharma reports Q2 2019 results 333

16.2.4 Apr 30, 2019: GC Pharma reports Q1 2019 results 333

16.3 Legal And Regulatory 333

16.3.1 Jun 03, 2019: Calmare Therapeutics receives favorable decision from The U.S. Court Of Appeals For The Second Circuit 333

16.3.2 Mar 19, 2019: Calmare Therapeutics has $10.4 million judgment vacated by the U.S. Court of Appeals for The Second Circuit 334

16.4 Other Significant Developments 334

16.4.1 Aug 05, 2019: IBA signs contract to install Cyclone 70 system in South Korea 334

16.4.2 Jul 17, 2019: Janssen Korea and Johnson & Johnson Innovation announce launch of Seoul Innovation QuickFire Challenge in smart healthcare 334

16.4.3 Jul 15, 2019: CTI signs Memorandum of Understanding for strategic partnership with Samsung Medical Center 335

16.4.4 May 09, 2019: NanoCellect Biomedical announces distribution to Korea 335

16.4.5 Apr 23, 2019: Macrogen and Exosome Plus to jointly develop exosome-based diagnostic and treatment solutions 336

16.5 Product News 336

16.5.1 Sep 17, 2019: Psomagen and Macrogen granted U.S. patent for Blockchain data-sharing Technology 336

16.5.2 Aug 19, 2019: MilliporeSigma granted 20 CRISPR patents total worldwide 337

16.5.3 May 28, 2019: Lunit to present findings on the predictive power of AI biomarker for lung cancer immunotherapy at ASCO 2019 338

16.5.4 Mar 14, 2019: Calgary-made blood test set to revolutionize breast cancer treatment 338

17 Appendix 340

17.1 Research Methodology 341

17.1.1 Coverage 341

17.1.2 Secondary Research 341

17.1.3 Primary Research 342

17.1.4 Market Modeling and Forecasting 343

17.1.5 Company Share Analysis 344

17.1.6 Distribution Share Analysis 345

17.1.7 Benchmarking 345

17.2 GlobalData Consulting 345

17.3 Contact Us 346

17.4 Disclaimer 346

Table

1.1 List of Tables

Table 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2015-2025 44

Table 2: In Vitro Diagnostics Market, South Korea, Category Contribution by Revenue ($m), 2018 47

Table 3: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2015-2020 49

Table 4: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2021-2025 50

Table 5: In Vitro Diagnostics Market, South Korea, Volume (Units), 2015-2025 52

Table 6: In Vitro Diagnostics Market, South Korea, Volume (Units), Historic, 2015-2020 54

Table 7: In Vitro Diagnostics Market, South Korea, Volume (Units), Forecast, 2021-2025 55

Table 8: In Vitro Diagnostics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 57

Table 9: Cardiac Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2020 59

Table 10: Cardiac Disease Market, South Korea, Revenue ($m), USD Constant, 2021-2025 59

Table 11: Cardiac Marker Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 61

Table 12: Cardiac Marker Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 62

Table 13: Cardiac Disease Market, South Korea, Volume (Units), 2015-2020 64

Table 14: Cardiac Disease Market, South Korea, Volume (Units), 2021-2025 64

Table 15: Cardiac Marker Tests Market, South Korea, Volume (Units), 2015-2020 66

Table 16: Cardiac Marker Tests Market, South Korea, Volume (Units), 2021-2025 67

Table 17: Cardiac Disease Market, South Korea, Average Price ($), 2015-2020 68

Table 18: Cardiac Disease Market, South Korea, Average Price ($), 2021-2025 69

Table 19: Cardiac Disease Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 70

Table 20: Cardiac Disease Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 72

Table 21: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, 2015-2020 74

Table 22: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, 2021-2025 74

Table 23: Substrates Market, South Korea, Revenue ($m), USD Constant, 2015-2020 76

Table 24: Substrates Market, South Korea, Revenue ($m), USD Constant, 2021-2025 77

Table 25: Clinical Chemistry Market, South Korea, Volume (Units), 2015-2020 79

Table 26: Clinical Chemistry Market, South Korea, Volume (Units), 2021-2025 79

Table 27: Substrates Market, South Korea, Volume (Units), 2015-2020 81

Table 28: Substrates Market, South Korea, Volume (Units), 2021-2025 82

Table 29: Clinical Chemistry Market, South Korea, Average Price ($), 2015-2020 83

Table 30: Clinical Chemistry Market, South Korea, Average Price ($), 2021-2025 84

Table 31: Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 85

Table 32: Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 86

Table 33: Hematological Disorders Market, South Korea, Segment Contribution (%), 2018 88

Table 34: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2015-2020 90

Table 35: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2021-2025 90

Table 36: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 92

Table 37: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 93

Table 38: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 95

Table 39: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 96

Table 40: Hematological Disorders Market, South Korea, Volume (Units), 2015-2020 98

Table 41: Hematological Disorders Market, South Korea, Volume (Units), 2021-2025 98

Table 42: Hematology Tests Market, South Korea, Volume (Units), 2015-2020 100

Table 43: Hematology Tests Market, South Korea, Volume (Units), 2021-2025 101

Table 44: Hemostasis Tests Market, South Korea, Volume (Units), 2015-2020 103

Table 45: Hemostasis Tests Market, South Korea, Volume (Units), 2021-2025 104

Table 46: Hematological Disorders Market, South Korea, Average Price ($), 2015-2020 105

Table 47: Hematological Disorders Market, South Korea, Average Price ($), 2021-2025 107

Table 48: Hematological Disorders Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 109

Table 49: Hematological Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 111

Table 50: Hormonal Disorders Market, South Korea, Revenue ($m), USD Constant, 2015-2020 113

Table 51: Hormonal Disorders Market, South Korea, Revenue ($m), USD Constant, 2021-2025 113

Table 52: Thyroid Function Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 115

Table 53: Thyroid Function Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 116

Table 54: Hormonal Disorders Market, South Korea, Volume (Units), 2015-2020 118

Table 55: Hormonal Disorders Market, South Korea, Volume (Units), 2021-2025 118

Table 56: Thyroid Function Tests Market, South Korea, Volume (Units), 2015-2020 120

Table 57: Thyroid Function Tests Market, South Korea, Volume (Units), 2021-2025 121

Table 58: Hormonal Disorders Market, South Korea, Average Price ($), 2015-2020 122

Table 59: Hormonal Disorders Market, South Korea, Average Price ($), 2021-2025 123

Table 60: Hormonal Disorders Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 124

Table 61: Hormonal Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 126

Table 62: Infectious Disease Market, South Korea, Segment Contribution (%), 2018 129

Table 63: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2020 131

Table 64: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2021-2025 132

Table 65: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 134

Table 66: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 134

Table 67: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 136

Table 68: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 137

Table 69: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 139

Table 70: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 139

Table 71: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 141

Table 72: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 141

Table 73: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 143

Table 74: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 144

Table 75: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 146

Table 76: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 146

Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 148

Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 148

Table 79: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 150

Table 80: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 150

Table 81: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 152

Table 82: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 152

Table 83: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 154

Table 84: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 155

Table 85: Infectious Disease Market, South Korea, Volume (Units), 2015-2020 157

Table 86: Infectious Disease Market, South Korea, Volume (Units), 2021-2025 159

Table 87: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2015-2020 162

Table 88: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2021-2025 162

Table 89: Clostridium difficile Tests Market, South Korea, Volume (Units), 2015-2020 164

Table 90: Clostridium difficile Tests Market, South Korea, Volume (Units), 2021-2025 165

Table 91: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2015-2020 167

Table 92: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2021-2025 167

Table 93: Hepatitis Tests Market, South Korea, Volume (Units), 2015-2020 169

Table 94: Hepatitis Tests Market, South Korea, Volume (Units), 2021-2025 169

Table 95: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2015-2020 171

Table 96: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2021-2025 172

Table 97: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2015-2020 174

Table 98: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2021-2025 174

Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2015-2020 176

Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2021-2025 176

Table 101: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2015-2020 178

Table 102: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2021-2025 178

Table 103: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2015-2020 180

Table 104: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2021-2025 180

Table 105: Treponema pallidum Tests Market, South Korea, Volume (Units), 2015-2020 182

Table 106: Treponema pallidum Tests Market, South Korea, Volume (Units), 2021-2025 183

Table 107: Infectious Disease Market, South Korea, Average Price ($), 2015-2020 184

Table 108: Infectious Disease Market, South Korea, Average Price ($), 2021-2025 187

Table 109: Infectious Disease Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 190

Table 110: Infectious Disease Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 192

Table 111: IVD Analyzers and Reagents Market, South Korea, Segment Contribution (%), 2018 194

Table 112: IVD Analyzers and Reagents Market, South Korea, Revenue ($m), USD Constant, 2015-2020 196

Table 113: IVD Analyzers and Reagents Market, South Korea, Revenue ($m), USD Constant, 2021-2025 197

Table 114: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2020 199

Table 115: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2021-2025 199

Table 116: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2020 201

Table 117: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, 2021-2025 202

Table 118: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2020 204

Table 119: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2021-2025 205

Table 120: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, 2015-2020 207

Table 121: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, 2021-2025 208

Table 122: IVD Analyzers and Reagents Market, South Korea, Volume (Units), 2015-2020 210

Table 123: IVD Analyzers and Reagents Market, South Korea, Volume (Units), 2021-2025 211

Table 124: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), 2015-2020 213

Table 125: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), 2021-2025 213

Table 126: Hematology Analyzers Market, South Korea, Volume (Units), 2015-2020 215

Table 127: Hematology Analyzers Market, South Korea, Volume (Units), 2021-2025 216

Table 128: Immunochemistry Analyzers Market, South Korea, Volume (Units), 2015-2020 218

Table 129: Immunochemistry Analyzers Market, South Korea, Volume (Units), 2021-2025 219

Table 130: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), 2015-2020 221

Table 131: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), 2021-2025 222

Table 132: IVD Analyzers and Reagents Market, South Korea, Average Price ($), 2015-2020 223

Table 133: IVD Analyzers and Reagents Market, South Korea, Average Price ($), 2021-2025 225

Table 134: IVD Analyzers and Reagents Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 227

Table 135: IVD Analyzers and Reagents Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 229

Table 136: Metabolic Disorder Market, South Korea, Revenue ($m), USD Constant, 2015-2020 231

Table 137: Metabolic Disorder Market, South Korea, Revenue ($m), USD Constant, 2021-2025 231

Table 138: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2015-2020 233

Table 139: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2021-2025 234

Table 140: Metabolic Disorder Market, South Korea, Volume (Units), 2015-2020 236

Table 141: Metabolic Disorder Market, South Korea, Volume (Units), 2021-2025 236

Table 142: Diabetes Assays Market, South Korea, Volume (Units), 2015-2020 238

Table 143: Diabetes Assays Market, South Korea, Volume (Units), 2021-2025 239

Table 144: Metabolic Disorder Market, South Korea, Average Price ($), 2015-2020 240

Table 145: Metabolic Disorder Market, South Korea, Average Price ($), 2021-2025 241

Table 146: Metabolic Disorder Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 242

Table 147: Metabolic Disorder Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 244

Table 148: Oncology Market, South Korea, Segment Contribution (%), 2018 246

Table 149: Oncology Market, South Korea, Revenue ($m), USD Constant, 2015-2020 249

Table 150: Oncology Market, South Korea, Revenue ($m), USD Constant, 2021-2025 250

Table 151: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 252

Table 152: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 252

Table 153: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 254

Table 154: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 254

Table 155: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 256

Table 156: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 256

Table 157: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 258

Table 158: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 259

Table 159: HER2 Amplification Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 261

Table 160: HER2 Amplification Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 261

Table 161: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 263

Table 162: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 263

Table 163: Oncology Market, South Korea, Volume (Units), 2015-2020 265

Table 164: Oncology Market, South Korea, Volume (Units), 2021-2025 266

Table 165: ALK Tests Market, South Korea, Volume (Units), 2015-2020 268

Table 166: ALK Tests Market, South Korea, Volume (Units), 2021-2025 268

Table 167: BRCA Tests Market, South Korea, Volume (Units), 2015-2020 270

Table 168: BRCA Tests Market, South Korea, Volume (Units), 2021-2025 270

Table 169: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2015-2020 272

Table 170: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2021-2025 272

Table 171: EGFR Tests Market, South Korea, Volume (Units), 2015-2020 274

Table 172: EGFR Tests Market, South Korea, Volume (Units), 2021-2025 275

Table 173: HER2 Amplification Tests Market, South Korea, Volume (Units), 2015-2020 277

Table 174: HER2 Amplification Tests Market, South Korea, Volume (Units), 2021-2025 277

Table 175: KRAS Tests Market, South Korea, Volume (Units), 2015-2020 279

Table 176: KRAS Tests Market, South Korea, Volume (Units), 2021-2025 279

Table 177: Oncology Market, South Korea, Average Price ($), 2015-2020 280

Table 178: Oncology Market, South Korea, Average Price ($), 2021-2025 282

Table 179: Oncology Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 284

Table 180: Oncology Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 286

Table 181: Women's Health Market, South Korea, Segment Contribution (%), 2018 288

Table 182: Women's Health Market, South Korea, Revenue ($m), USD Constant, 2015-2020 290

Table 183: Women's Health Market, South Korea, Revenue ($m), USD Constant, 2021-2025 290

Table 184: Prenatal Screening Market, South Korea, Revenue ($m), USD Constant, 2015-2020 292

Table 185: Prenatal Screening Market, South Korea, Revenue ($m), USD Constant, 2021-2025 293

Table 186: Reproductive Hormones and Proteins Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2020 295

Table 187: Reproductive Hormones and Proteins Tests Market, South Korea, Revenue ($m), USD Constant, 2021-2025 296

Table 188: Women's Health Market, South Korea, Volume (Units), 2015-2020 298

Table 189: Women's Health Market, South Korea, Volume (Units), 2021-2025 298

Table 190: Prenatal Screening Market, South Korea, Volume (Units), 2015-2020 300

Table 191: Prenatal Screening Market, South Korea, Volume (Units), 2021-2025 301

Table 192: Reproductive Hormones and Proteins Tests Market, South Korea, Volume (Units), 2015-2020 303

Table 193: Reproductive Hormones and Proteins Tests Market, South Korea, Volume (Units), 2021-2025 304

Table 194: Women's Health Market, South Korea, Average Price ($), 2015-2020 305

Table 195: Women's Health Market, South Korea, Average Price ($), 2021-2025 307

Table 196: Women's Health Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2018 309

Table 197: Women's Health Market, South Korea, Company Share by Revenue ($m), USD Constant, 2018 311

Table 198: In Vitro Diagnostics Market Pipeline Products 316

Table 199: Sugentech to Raise USD8.4 Million in Private Placement of Bonds Due 2024 320

Table 200: TCM Bioscience to Raise Funds through IPO 321

Table 201: Sugentech to Raise up to USD18.5 Million in Public Offering of Shares 322

Table 202: Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 323

Table 203: Volpara Solutions Enters into Distribution Agreement with ScreenPoint Medical 324

Table 204: FutureChem Enters into Research Agreement with University of Colombia 325

Table 205: Wellmarker Bio Enters into R&D Agreement with Cytogen 326

Table 206: 3billion Raises USD9.5 Million in Series B Financing 327

Table 207: Genopsy Raises USD8.5 Million in Series A Financing 329

Table 208: Milu Labs Raises Funds through Seed Financing 330

Table 209: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 343

Figures

1.2 List of Figures

Figure 1: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, 2015-2025 43

Figure 2: In Vitro Diagnostics Market, South Korea, Revenue Mix ($m), 2018 45

Figure 3: In Vitro Diagnostics Market, South Korea, Category Contribution (%), 2018 46

Figure 4: In Vitro Diagnostics Market, South Korea, Revenue ($m), USD Constant, Historic, 2015-2025 48

Figure 5: In Vitro Diagnostics Market, South Korea, Volume (Units), 2015-2025 51

Figure 6: In Vitro Diagnostics Market, South Korea, Volume (Units), Historic, 2015-2025 53

Figure 7: In Vitro Diagnostics Market, South Korea, Company Share (%) 2018 56

Figure 8: Cardiac Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2025 58

Figure 9: Cardiac Marker Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 60

Figure 10: Cardiac Disease Market, South Korea, Volume (Units), 2015-2025 63

Figure 11: Cardiac Marker Tests Market, South Korea, Volume (Units), 2015-2025 65

Figure 12: Cardiac Disease Market, South Korea, Company Share (%) 2018 71

Figure 13: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, 2015-2025 73

Figure 14: Substrates Market, South Korea, Revenue ($m), USD Constant, 2015-2025 75

Figure 15: Clinical Chemistry Market, South Korea, Volume (Units), 2015-2025 78

Figure 16: Substrates Market, South Korea, Volume (Units), 2015-2025 80

Figure 17: Clinical Chemistry Market, South Korea, Company Share (%) 2018 86

Figure 18: Hematological Disorders Market, South Korea, Revenue Mix ($m), 2018 87

Figure 19: Hematological Disorders Market, South Korea, Segment Contribution (%), 2018 88

Figure 20: Hematological Disorders Market, South Korea, Revenue ($m), USD Constant, 2015-2025 89

Figure 21: Hematology Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 91

Figure 22: Hemostasis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 94

Figure 23: Hematological Disorders Market, South Korea, Volume (Units), 2015-2025 97

Figure 24: Hematology Tests Market, South Korea, Volume (Units), 2015-2025 99

Figure 25: Hemostasis Tests Market, South Korea, Volume (Units), 2015-2025 102

Figure 26: Hematological Disorders Market, South Korea, Company Share (%) 2018 110

Figure 27: Hormonal Disorders Market, South Korea, Revenue ($m), USD Constant, 2015-2025 112

Figure 28: Thyroid Function Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 114

Figure 29: Hormonal Disorders Market, South Korea, Volume (Units), 2015-2025 117

Figure 30: Thyroid Function Tests Market, South Korea, Volume (Units), 2015-2025 119

Figure 31: Hormonal Disorders Market, South Korea, Company Share (%) 2018 125

Figure 32: Infectious Disease Market, South Korea, Revenue Mix ($m), 2018 127

Figure 33: Infectious Disease Market, South Korea, Segment Contribution (%), 2018 128

Figure 34: Infectious Disease Market, South Korea, Revenue ($m), USD Constant, 2015-2025 130

Figure 35: Chlamydia Trachomatis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 133

Figure 36: Clostridium difficile Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 135

Figure 37: Cytomegalovirus (CMV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 138

Figure 38: Hepatitis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 140

Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 142

Figure 40: Human Papilloma Virus (HPV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 145

Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 147

Figure 42: Mycobacterium Tuberculosis Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 149

Figure 43: Neisseria Gonorrhoeae Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 151

Figure 44: Treponema pallidum Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 153

Figure 45: Infectious Disease Market, South Korea, Volume (Units), 2015-2025 156

Figure 46: Chlamydia Trachomatis Tests Market, South Korea, Volume (Units), 2015-2025 161

Figure 47: Clostridium difficile Tests Market, South Korea, Volume (Units), 2015-2025 163

Figure 48: Cytomegalovirus (CMV) Tests Market, South Korea, Volume (Units), 2015-2025 166

Figure 49: Hepatitis Tests Market, South Korea, Volume (Units), 2015-2025 168

Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, South Korea, Volume (Units), 2015-2025 170

Figure 51: Human Papilloma Virus (HPV) Tests Market, South Korea, Volume (Units), 2015-2025 173

Figure 52: Human T-Lymphotropic Virus (HTLV) Tests Market, South Korea, Volume (Units), 2015-2025 175

Figure 53: Mycobacterium Tuberculosis Tests Market, South Korea, Volume (Units), 2015-2025 177

Figure 54: Neisseria Gonorrhoeae Tests Market, South Korea, Volume (Units), 2015-2025 179

Figure 55: Treponema pallidum Tests Market, South Korea, Volume (Units), 2015-2025 181

Figure 56: Infectious Disease Market, South Korea, Company Share (%) 2018 191

Figure 57: IVD Analyzers and Reagents Market, South Korea, Revenue Mix ($m), 2018 193

Figure 58: IVD Analyzers and Reagents Market, South Korea, Segment Contribution (%), 2018 194

Figure 59: IVD Analyzers and Reagents Market, South Korea, Revenue ($m), USD Constant, 2015-2025 195

Figure 60: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2025 198

Figure 61: Hematology Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2025 200

Figure 62: Immunochemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, 2015-2025 203

Figure 63: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Revenue ($m), USD Constant, 2015-2025 206

Figure 64: IVD Analyzers and Reagents Market, South Korea, Volume (Units), 2015-2025 209

Figure 65: Clinical Chemistry Analyzers Market, South Korea, Volume (Units), 2015-2025 212

Figure 66: Hematology Analyzers Market, South Korea, Volume (Units), 2015-2025 214

Figure 67: Immunochemistry Analyzers Market, South Korea, Volume (Units), 2015-2025 217

Figure 68: Polymerase Chain Reaction (PCR) Systems Market, South Korea, Volume (Units), 2015-2025 220

Figure 69: IVD Analyzers and Reagents Market, South Korea, Company Share (%) 2018 228

Figure 70: Metabolic Disorder Market, South Korea, Revenue ($m), USD Constant, 2015-2025 230

Figure 71: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2015-2025 232

Figure 72: Metabolic Disorder Market, South Korea, Volume (Units), 2015-2025 235

Figure 73: Diabetes Assays Market, South Korea, Volume (Units), 2015-2025 237

Figure 74: Metabolic Disorder Market, South Korea, Company Share (%) 2018 243

Figure 75: Oncology Market, South Korea, Revenue Mix ($m), 2018 245

Figure 76: Oncology Market, South Korea, Segment Contribution (%), 2018 246

Figure 77: Oncology Market, South Korea, Revenue ($m), USD Constant, 2015-2025 248

Figure 78: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 251

Figure 79: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 253

Figure 80: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 255

Figure 81: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 257

Figure 82: HER2 Amplification Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 260

Figure 83: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 262

Figure 84: Oncology Market, South Korea, Volume (Units), 2015-2025 264

Figure 85: ALK Tests Market, South Korea, Volume (Units), 2015-2025 267

Figure 86: BRCA Tests Market, South Korea, Volume (Units), 2015-2025 269

Figure 87: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2015-2025 271

Figure 88: EGFR Tests Market, South Korea, Volume (Units), 2015-2025 273

Figure 89: HER2 Amplification Tests Market, South Korea, Volume (Units), 2015-2025 276

Figure 90: KRAS Tests Market, South Korea, Volume (Units), 2015-2025 278

Figure 91: Oncology Market, South Korea, Company Share (%) 2018 285

Figure 92: Women's Health Market, South Korea, Revenue Mix ($m), 2018 287

Figure 93: Women's Health Market, South Korea, Segment Contribution (%), 2018 288

Figure 94: Women's Health Market, South Korea, Revenue ($m), USD Constant, 2015-2025 289

Figure 95: Prenatal Screening Market, South Korea, Revenue ($m), USD Constant, 2015-2025 291

Figure 96: Reproductive Hormones and Proteins Tests Market, South Korea, Revenue ($m), USD Constant, 2015-2025 294

Figure 97: Women's Health Market, South Korea, Volume (Units), 2015-2025 297

Figure 98: Prenatal Screening Market, South Korea, Volume (Units), 2015-2025 299

Figure 99: Reproductive Hormones and Proteins Tests Market, South Korea, Volume (Units), 2015-2025 302

Figure 100: Women's Health Market, South Korea, Company Share (%) 2018 310

Frequently asked questions

South Korea In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at South Korea In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. in real time.

  • Access a live South Korea In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more